• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高海拔地区 COVID-19 发病率和死亡率的差异。

Disparities in COVID-19 incidence and fatality rates at high-altitude.

机构信息

CSIR-Institute of Genomics and Integrative Biology, Genomics and Molecular Medicine, Delhi, India.

Institute of Hypoxia Research, New Delhi, India.

出版信息

PeerJ. 2023 Feb 6;11:e14473. doi: 10.7717/peerj.14473. eCollection 2023.

DOI:10.7717/peerj.14473
PMID:36788813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9922493/
Abstract

BACKGROUND

SARS-CoV-2 has affected every demography disproportionately, including even the native highland populations. Hypobaric-hypoxic settings at high-altitude (HA, >2,500 masl) present an extreme environment that impacts the survival of permanent residents, possibly including SARS-CoV-2. Conflicting hypotheses have been presented for COVID-19 incidence and fatality at HA.

OBJECTIVES

To evaluate protection or risk against COVID-19 incidence and fatality in humans under hypobaric-hypoxic environment of high-altitude (>2,501 masl).

METHODS

Global COVID-19 data of March 2020-21, employed from official websites of the Indian Government, John Hopkins University, and Worldometer were clustered into 6 altitude categories. Clinical cofactors and comorbidities data were evaluated with COVID-19 incidence and fatality. Extensive comparisons and correlations using several statistical tools estimated the risk and protection.

RESULTS

Of relevance, data analyses revealed four distinct responses, namely, partial risk, total risk, partial protection, and total protection from COVID-19 at high-altitude indicating a mixed baggage and complexity of the infection. Surprisingly, it included the countries within the same geographic region. Moreover, body mass index, hypertension, and diabetes correlated significantly with COVID-19 incidence and fatality rate ( ≤ 0.05).

CONCLUSIONS

Varied patterns of protection and risk against COVID-19 incidence and fatality were observed among the high-altitude populations. It is though premature to generalize COVID-19 effects on any particular demography without further extensive studies.

摘要

背景

SARS-CoV-2 对不同人群的影响不均衡,甚至包括当地的高原人群。高海拔(HA,>2500 米)的低气压-低氧环境是一个极端环境,可能会影响常驻居民的生存,包括 SARS-CoV-2。对于高海拔地区 COVID-19 的发病率和死亡率,存在相互矛盾的假说。

目的

评估人类在高海拔(>2501 米)低气压-低氧环境下对 COVID-19 发病率和死亡率的保护或风险。

方法

采用 2020 年 3 月至 21 月全球 COVID-19 数据,来源于印度政府、约翰霍普金斯大学和世界卫生组织的官方网站。将临床合并症和合并症数据与 COVID-19 的发病率和死亡率进行评估。使用多种统计工具进行广泛比较和相关性分析,以评估风险和保护。

结果

值得注意的是,数据分析显示了四种不同的反应,即高海拔地区 COVID-19 的部分风险、全部风险、部分保护和全部保护,这表明了感染的复杂性和混合性。令人惊讶的是,它包括了同一地理区域内的国家。此外,体重指数、高血压和糖尿病与 COVID-19 的发病率和死亡率显著相关(≤0.05)。

结论

在高海拔地区人群中观察到 COVID-19 发病率和死亡率的保护和风险存在不同模式。在没有进一步广泛研究的情况下,对任何特定人群的 COVID-19 影响进行概括还为时过早。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418f/9922493/5b627bbf2a3a/peerj-11-14473-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418f/9922493/554af1f3c7e2/peerj-11-14473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418f/9922493/5b627bbf2a3a/peerj-11-14473-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418f/9922493/554af1f3c7e2/peerj-11-14473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/418f/9922493/5b627bbf2a3a/peerj-11-14473-g002.jpg

相似文献

1
Disparities in COVID-19 incidence and fatality rates at high-altitude.高海拔地区 COVID-19 发病率和死亡率的差异。
PeerJ. 2023 Feb 6;11:e14473. doi: 10.7717/peerj.14473. eCollection 2023.
2
Incidence of COVID-19 infection and prevalence of diabetes, obesity and hypertension according to altitude in Peruvian population.秘鲁人群中 COVID-19 感染发病率及糖尿病、肥胖和高血压患病率与海拔的关系。
Diabetes Res Clin Pract. 2020 Nov;169:108463. doi: 10.1016/j.diabres.2020.108463. Epub 2020 Sep 22.
3
Altitude and COVID-19 in Colombia: An updated analysis accounting for potential confounders.哥伦比亚的海拔高度与2019冠状病毒病:一项考虑潜在混杂因素的最新分析。
Respir Physiol Neurobiol. 2023 Oct;316:104136. doi: 10.1016/j.resp.2023.104136. Epub 2023 Aug 1.
4
Negative Correlation between Altitude and COVID-19 Pandemic in Colombia: A Preliminary Report.哥伦比亚的海拔与 COVID-19 大流行呈负相关:初步报告。
Am J Trop Med Hyg. 2020 Dec;103(6):2347-2349. doi: 10.4269/ajtmh.20-1027. Epub 2020 Oct 26.
5
Revisiting the COVID-19 fatality rate and altitude association through a comprehensive analysis.通过全面分析重新审视新冠病毒疾病(COVID-19)死亡率与海拔高度的关联
Sci Rep. 2022 Oct 27;12(1):18048. doi: 10.1038/s41598-022-21787-z.
6
Decreased incidence, virus transmission capacity, and severity of COVID-19 at altitude on the American continent.在美洲大陆的高海拔地区,COVID-19 的发病率、病毒传播能力和严重程度都有所降低。
PLoS One. 2021 Mar 29;16(3):e0237294. doi: 10.1371/journal.pone.0237294. eCollection 2021.
7
SARS-CoV-2 Viral Load Analysis at Low and High Altitude: A Case Study from Ecuador.SARS-CoV-2 病毒载量在低海拔和高海拔地区的分析:来自厄瓜多尔的案例研究。
Int J Environ Res Public Health. 2022 Jun 28;19(13):7945. doi: 10.3390/ijerph19137945.
8
Effect of altitude on COVID-19 mortality in Ecuador: an ecological study.厄瓜多尔 COVID-19 死亡率与海拔高度的关系:一项生态学研究。
BMC Public Health. 2021 Nov 12;21(1):2079. doi: 10.1186/s12889-021-12162-0.
9
Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.估算 2021 年 11 月 14 日前全球、区域和国家的 SARS-CoV-2 日感染和累计感染人数:一项统计分析。
Lancet. 2022 Jun 25;399(10344):2351-2380. doi: 10.1016/S0140-6736(22)00484-6. Epub 2022 Apr 8.
10
Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.在 2020 年春季大流行期间估计 SARS-CoV-2 在纽约市的感染病死率:基于模型的分析。
Lancet Infect Dis. 2021 Feb;21(2):203-212. doi: 10.1016/S1473-3099(20)30769-6. Epub 2020 Oct 19.

引用本文的文献

1
Death Risk Response of High-Altitude Resident Populations to COVID-19 Vaccine: A Retrospective Cohort Study.高原居住人群对新冠病毒疫苗的死亡风险反应:一项回顾性队列研究
High Alt Med Biol. 2025 Mar;26(1):37-44. doi: 10.1089/ham.2024.0045. Epub 2024 Jul 23.
2
Development and validation of a scoring system to predict mortality in patients hospitalized with COVID-19: A retrospective cohort study in two large hospitals in Ecuador.开发和验证一种评分系统以预测 COVID-19 住院患者的死亡率:厄瓜多尔两家大型医院的回顾性队列研究。
PLoS One. 2023 Jul 17;18(7):e0288106. doi: 10.1371/journal.pone.0288106. eCollection 2023.

本文引用的文献

1
Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches.使用基于计算和深度学习的方法鉴定 SARS-CoV-2 冠状病毒的疫苗靶点和设计疫苗。
PeerJ. 2022 May 19;10:e13380. doi: 10.7717/peerj.13380. eCollection 2022.
2
High-altitude is associated with better short-term survival in critically ill COVID-19 patients admitted to the ICU.高海拔地区与 ICU 收治的危重症 COVID-19 患者的短期生存改善相关。
PLoS One. 2022 Mar 31;17(3):e0262423. doi: 10.1371/journal.pone.0262423. eCollection 2022.
3
Analysis of Excess Mortality Data at Different Altitudes During the COVID-19 Outbreak in Ecuador.
厄瓜多尔新冠疫情期间不同海拔地区超额死亡率数据分析
High Alt Med Biol. 2021 Dec;22(4):406-416. doi: 10.1089/ham.2021.0070.
4
Effect of altitude on COVID-19 mortality in Ecuador: an ecological study.厄瓜多尔 COVID-19 死亡率与海拔高度的关系:一项生态学研究。
BMC Public Health. 2021 Nov 12;21(1):2079. doi: 10.1186/s12889-021-12162-0.
5
Diabetes increases the risk of COVID-19 in an altitude dependent manner: An analysis of 1,280,806 Mexican patients.糖尿病以依赖海拔的方式增加 COVID-19 的风险:对 1280806 名墨西哥患者的分析。
PLoS One. 2021 Aug 3;16(8):e0255144. doi: 10.1371/journal.pone.0255144. eCollection 2021.
6
Altitude does not protect against SARS-CoV-2 infections and mortality due to COVID-19.海拔高度并不能预防新型冠状病毒肺炎(COVID-19)导致的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染和死亡。
Physiol Rep. 2021 Jun;9(11):e14922. doi: 10.14814/phy2.14922.
7
Potential Protective Effect from COVID-19 Conferred by Altitude: A Longitudinal Analysis in Peru During Full Lockdown.高海拔地区对 COVID-19 的潜在保护作用:秘鲁全面封锁期间的纵向分析。
High Alt Med Biol. 2021 Jun;22(2):209-224. doi: 10.1089/ham.2020.0202. Epub 2021 Mar 29.
8
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.确保全球公平获得 COVID-19 疫苗面临的挑战:生产、可负担性、分配和部署。
Lancet. 2021 Mar 13;397(10278):1023-1034. doi: 10.1016/S0140-6736(21)00306-8. Epub 2021 Feb 12.
9
COVID-19 vaccines: where we stand and challenges ahead.COVID-19 疫苗:我们的现状和未来的挑战。
Cell Death Differ. 2021 Feb;28(2):626-639. doi: 10.1038/s41418-020-00720-9. Epub 2021 Jan 21.
10
Impact of altitude on COVID-19 infection and death in the United States: A modeling and observational study.美国海拔高度对 COVID-19 感染和死亡的影响:建模和观察研究。
PLoS One. 2021 Jan 14;16(1):e0245055. doi: 10.1371/journal.pone.0245055. eCollection 2021.